Absolutely amazing and stimulating keynote lecture by ⁦Claire Harrison⁩ on #MPNsm at the 6th annual meeting of GSG-MPN⁩ in ⁦@PresseamtAachen⁩. We are highly honoured to have you here ⁦Uniklinik RWTH AC⁩ ⁦RWTH Aachen⁩

Great time at the GSG-MPN study group meeting with fantastic discussions, exciting presentations and networking. Proud of Adam Benabid who presented our latest data on stromal reprogramming in #MPNsm. Uniklinik RWTH AC #Aachen #happyPI

Impressive days at the #EHA2023. Great educational sessions and exciting new data on #MPNsm 🩸 #GSGMPN GSG-MPN

Just published thanks to a joint effort by ⁦Susanne Isfort⁩ and Dominik Wolf 🙏: Step-in dosing of bosutinib in pts with CP CML after 2nd gen. TKI therapy: results of the BODO- Study - PubMed ⁦Uniklinik RWTH AC⁩ ⁦⁦GSG-MPN⁩ ⁦#cioabcd ⁦ pubmed.ncbi.nlm.nih.gov/37592092/

Interesting results about the accelerated cellular aging in the malignant clone of myeloproliferative neoplasms 👏 #MPNsm #telomere

Congratulations! S Koschmieder 👏 #myelofibrosis #MPN #CRU344 GSG-MPN

Another poster at the DGHO DGHO e. V. from our young scientists 👩‍🔬👨‍🔬. Great to see the passion for #MPN 🩸Congratulations👏 S Koschmieder Tim Brümmendorf #MPN #CRU344 #GSG-MPN GSG-MPN

Congratulations to Prof. Hallek Michael Hallek and Prof. Brümmendorf Tim Brümmendorf for the presideny of the DGHO Annual Meeting in 2025 👏

The #telomerase inhibitor #imetelstat shortens #telomeres and differentially targets #JAK2V617F versus #CALR mutant myeloproliferative neoplasm (#MPN) cells and inhibits JAK-STAT signaling frontiersin.org/articles/10.33… Uniklinik RWTH AC GSG-MPN MPN_Hub #cioabcd #telomere

Excellent opening talk of David Kent ⁦David Kent⁩ on #mpn drivers at our 3rd workshop of #CRU344 funded by ⁦DFG public | @[email protected]⁩ at beautiful Schloss Rahe in #aachen ⁦GSG-MPN⁩ ⁦Uniklinik RWTH AC⁩ ⁦RWTH Aachen⁩ ⁦MPN_Hub⁩ ⁦S Koschmieder⁩

Special thanks to our distinguished guest speakers for their outstanding talks! 👏 #cru344 #scientific meeting #mpn #fibrosis

Another series of great talks on #mpn and #cml at day 2 of our 3rd workshop of #cru344 funded by ⁦DFG public | @[email protected]⁩ devoted to #myelofibrosis in #mpnsm. We couldn’t be more grateful to have Radek Skoda as our senior adviser ⁦Uniklinik RWTH AC⁩ #cioabcd ⁦@gsg-mpn

Two fantastic days with great talks and stimulating discussions. Thanks to all participants! 3rd #CRU344 scientific meeting 2023 at Schloss Rahe 🎉 #mpn GSG-MPN

⁦S Koschmieder⁩ from ⁦Uniklinik RWTH AC⁩ presenting an interim analysis of the #Pvera cohort of the #Ruxobeat trial of the ⁦GSG-MPN⁩ at #ASH2023. Ruxolitinib was more efficient in improving spleen size and selected symptoms over BAT in 1st line therapy #cioabcd

Interesting data and great presentation on the use of BET inhibitor BMS986158 in Myelofibrosis by Haifa Al-Ali #ASH2023 GSG-MPN : encouraging responses despite early data and low numbers of patients to date.

Great presentation by Joachim Goethert Hämatologie und Stammzelltransplantation, UK-Essen GSG-MPN on the efficacy and safety of LSD1 inhibitor Bomedemstat in ET #ASH2023 . Clinically relevant hematologic responses.

Sign up now ➡️cto-im3.de/gsgmpn/ for the 7th GSG-MPN study group meeting in Ulm 🩸 #mpn #germanstudygroup GSG-MPN

🔜See you next week! #MPNsm #GSGMPN #studygroupmeeting2024 GSG-MPN

Thanks to all speakers and participants for a great 7th study group meeting in Ulm! We had two exciting days with outstanding talks and stimulating discussions. See you next year in Aachen! 🩸👋 #MPNsm #GSGMPN #studygroupmeeting #ulm #aachen GSG-MPN

The DFG is funding the multicenter joint project "TARGET-MPN: Targeting disease persistence and progression in myeloproliferative neoplasms " over the next 4 years. Congratulations to Prof. Heidel FlorianHeidel, Prof. Pahl and colleagues. #MPN 👏 dfg.de/de/service/pre…